Herbert Samuels - Publications

Basic Medical Science New York University, New York, NY, United States 
Pharmacology, Biochemistry

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Das S, Yeung KT, Mahajan MA, Samuels HH. Fas Activated Serine-Threonine Kinase Domains 2 (FASTKD2) mediates apoptosis of breast and prostate cancer cells through its novel FAST2 domain. Bmc Cancer. 14: 852. PMID 25409762 DOI: 10.1186/1471-2407-14-852  0.44
2013 Tinnikov AA, Samuels HH. A novel cell lysis approach reveals that caspase-2 rapidly translocates from the nucleus to the cytoplasm in response to apoptotic stimuli. Plos One. 8: e61085. PMID 23596516 DOI: 10.1371/journal.pone.0061085  0.32
2012 Yang YJ, Baltus AE, Mathew RS, Murphy EA, Evrony GD, Gonzalez DM, Wang EP, Marshall-Walker CA, Barry BJ, Murn J, Tatarakis A, Mahajan MA, Samuels HH, Shi Y, Golden JA, et al. Microcephaly gene links trithorax and REST/NRSF to control neural stem cell proliferation and differentiation. Cell. 151: 1097-112. PMID 23178126 DOI: 10.1016/j.cell.2012.10.043  0.44
2011 Yeung KT, Das S, Zhang J, Lomniczi A, Ojeda SR, Xu CF, Neubert TA, Samuels HH. A novel transcription complex that selectively modulates apoptosis of breast cancer cells through regulation of FASTKD2. Molecular and Cellular Biology. 31: 2287-98. PMID 21444724 DOI: 10.1128/MCB.01381-10  0.44
2010 Goyanka R, Das S, Samuels HH, Cardozo T. Nuclear receptor engineering based on novel structure activity relationships revealed by farnesyl pyrophosphate. Protein Engineering, Design & Selection : Peds. 23: 809-15. PMID 20817759 DOI: 10.1093/protein/gzq056  0.44
2010 Vukelic S, Stojadinovic O, Pastar I, Vouthounis C, Krzyzanowska A, Das S, Samuels HH, Tomic-Canic M. Farnesyl pyrophosphate inhibits epithelialization and wound healing through the glucocorticoid receptor. The Journal of Biological Chemistry. 285: 1980-8. PMID 19903814 DOI: 10.1074/jbc.M109.016741  0.44
2009 Tinnikov AA, Yeung KT, Das S, Samuels HH. Identification of a novel pathway that selectively modulates apoptosis of breast cancer cells. Cancer Research. 69: 1375-82. PMID 19190336 DOI: 10.1158/0008-5472.CAN-08-2896  0.44
2009 Garapaty S, Xu CF, Trojer P, Mahajan MA, Neubert TA, Samuels HH. Identification and characterization of a novel nuclear protein complex involved in nuclear hormone receptor-mediated gene regulation. The Journal of Biological Chemistry. 284: 7542-52. PMID 19131338 DOI: 10.1074/jbc.M805872200  0.44
2008 Mahajan MA, Samuels HH. Nuclear receptor coactivator/coregulator NCoA6(NRC) is a pleiotropic coregulator involved in transcription, cell survival, growth and development. Nuclear Receptor Signaling. 6: e002. PMID 18301782 DOI: 10.1621/nrs.06002  0.44
2008 Garapaty S, Mahajan MA, Samuels HH. Components of the CCR4-NOT complex function as nuclear hormone receptor coactivators via association with the NRC-interacting Factor NIF-1. The Journal of Biological Chemistry. 283: 6806-16. PMID 18180299 DOI: 10.1074/jbc.M706986200  0.44
2007 Das S, Schapira M, Tomic-Canic M, Goyanka R, Cardozo T, Samuels HH. Farnesyl pyrophosphate is a novel transcriptional activator for a subset of nuclear hormone receptors. Molecular Endocrinology (Baltimore, Md.). 21: 2672-86. PMID 17666588 DOI: 10.1210/me.2007-0080  0.44
2007 Mahajan MA, Murray A, Levy D, Samuels HH. Nuclear receptor coregulator (NRC): mapping of the dimerization domain, activation of p53 and STAT-2, and identification of the activation domain AD2 necessary for nuclear receptor signaling. Molecular Endocrinology (Baltimore, Md.). 21: 1822-34. PMID 17536006 DOI: 10.1210/me.2005-0529  0.44
2007 Das S, Nwachukwu JC, Li D, Vulin AI, Martinez-Caballero S, Kinnally KW, Samuels HH. The nuclear receptor interacting factor-3 transcriptional coregulator mediates rapid apoptosis in breast cancer cells through direct and bystander-mediated events. Cancer Research. 67: 1775-82. PMID 17308120 DOI: 10.1158/0008-5472.CAN-06-4034  0.44
2006 Tian H, Mahajan MA, Wong CT, Habeos I, Samuels HH. The N-Terminal A/B domain of the thyroid hormone receptor-beta2 isoform influences ligand-dependent recruitment of coactivators to the ligand-binding domain. Molecular Endocrinology (Baltimore, Md.). 20: 2036-51. PMID 16645037 DOI: 10.1210/me.2005-0437  0.44
2005 Mahajan MA, Samuels HH. Nuclear hormone receptor coregulator: role in hormone action, metabolism, growth, and development. Endocrine Reviews. 26: 583-97. PMID 15561801 DOI: 10.1210/er.2004-0012  0.44
2004 Afonja O, Juste D, Das S, Matsuhashi S, Samuels HH. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis. Oncogene. 23: 8135-45. PMID 15361828 DOI: 10.1038/sj.onc.1207983  0.44
2004 Mahajan MA, Das S, Zhu H, Tomic-Canic M, Samuels HH. The nuclear hormone receptor coactivator NRC is a pleiotropic modulator affecting growth, development, apoptosis, reproduction, and wound repair. Molecular and Cellular Biology. 24: 4994-5004. PMID 15143190 DOI: 10.1128/MCB.24.11.4994-5004.2004  0.44
2004 Li D, Das S, Yamada T, Samuels HH. The NRIF3 family of transcriptional coregulators induces rapid and profound apoptosis in breast cancer cells. Molecular and Cellular Biology. 24: 3838-48. PMID 15082778  0.44
2003 Mathur M, Das S, Samuels HH. PSF-TFE3 oncoprotein in papillary renal cell carcinoma inactivates TFE3 and p53 through cytoplasmic sequestration. Oncogene. 22: 5031-44. PMID 12902986 DOI: 10.1038/sj.onc.1206643  0.44
2003 Schapira M, Raaka BM, Das S, Fan L, Totrov M, Zhou Z, Wilson SR, Abagyan R, Samuels HH. Discovery of diverse thyroid hormone receptor antagonists by high-throughput docking. Proceedings of the National Academy of Sciences of the United States of America. 100: 7354-9. PMID 12777627 DOI: 10.1073/pnas.1131854100  0.44
2002 Afonja O, Raaka BM, Huang A, Das S, Zhao X, Helmer E, Juste D, Samuels HH. RAR agonists stimulate SOX9 gene expression in breast cancer cell lines: evidence for a role in retinoid-mediated growth inhibition. Oncogene. 21: 7850-60. PMID 12420222 DOI: 10.1038/sj.onc.1205985  0.44
2002 Mahajan MA, Murray A, Samuels HH. NRC-interacting factor 1 is a novel cotransducer that interacts with and regulates the activity of the nuclear hormone receptor coactivator NRC. Molecular and Cellular Biology. 22: 6883-94. PMID 12215545 DOI: 10.1128/MCB.22.19.6883-6894.2002  0.44
Show low-probability matches.